Los Angeles Business Journal

LA HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

MannKind Shares Fall on FDA Delay

Shares of MannKind Corp. fell nearly 8 percent Monday after the company announced that the FDA’s final decision on its inhalable insulin could be delayed beyond an expected April 15 deadline.

Tease photo

Healthy Votes of Approval for Inhalable Insulin

BIOTECH: MannKind stock rises after its device receives FDA panel’s OK.

Shares of MannKind climb after its inhalable insulin device receives FDA panel’s approval.

Amgen Cancer Drug Results Disappoint

Shares of Amgen Inc. fell 4 percent on Friday after the Thousand Oaks biotech giant said an experimental skin cancer drug had not significantly improved survival rates in clinical trial patients although it reduced the size of tumors.

Amgen Ends GlaxoSmithKline Partnership

Amgen Inc. on Thursday said it would pay GlaxoSmithKline more than $275 million to get out of a co-marketing agreement with the British drug company to promote Amgen’s osteoporosis drug Prolia in certain regions outside the United States.

Response Genetics Adds More Health Plans to Client List

Shares of Response Genetics Inc. jumped 18 percent on Thursday after the cancer diagnostic test company signed agreements with six additional health plans and two large health care groups.

FDA Panel Recommends Approval of MannKind's Afrezza

MannKind Corp.'s share price more than doubled in after-hours trading Tuesday, following news that an FDA advisory panel had finally recommended approval of the Valencia company's Afrezza insulin inhaler.

Fresenius Invests in Apollo Medical

Apollo Medical Holdings Inc. on Monday said it secured up to $12 million in capital from Fresenius Medical Care North America, a chain of dialysis clinics in Waltham, Mass.

Tease photo

USC Medical Center Doubles Up in Downtown

TREATMENT: Keck sees patient volume soar after move closer to L.A. Live.

Hotels and nightlife venues aren’t the only establishments finding success by being near L.A. Live.

FDA Could Limit MannKind Inhaler

Shares of MannKind Corp. fell 7 percent on Friday after the FDA staff raised safety questions about the company’s inhalable insulin device, which could limit its use for certain patients.

Herbalife Shares Rise as Icahn Gets More of Board

Herbalife shares rose Monday after the company announced it is nominating three more designees of Carl Icahn to its board.

Tease photo

Firm Builds Tech Bridge Between Asia, Middle East

INVESTMENT: DPL taps South Korean money to back Israeli startups.

Trio gives birth to $50 million fund that will nurse Israeli life sciences startups with South Korean money.

Herbalife Foe Reaps Democrats’ Liberal Assistance

OP-ED

Bill Gunderson shares the story of how Democratic operatives were enlisted to short Herbalife stock.

Tease photo

Businesses Still Battle Disability Suits

LAW: Plaintiff attorneys raise costs by going straight to filing.

Reform intended to curb abuse of the Americans With Disabilities Act has not stopped business owners from being sued multiple times for the same infraction.

Apollo Signs Deal with Rite Aid

Apollo Medical Holdings Inc. announced on Tuesday that it is partnering with Rite Aid Corp. to help manage the health of patients with chronic conditions.

FDA Panel Backs Staar Product

Shares of Staar Surgical Co. jumped 15 percent on Monday after the lens company announced that a Food and Drug Administration advisory panel had recommended U.S. marketing approval for an implantable eye lens.